Navigation Links
Partnership Formed to Explore Personalized Medicine Approach for Amyotrophic Lateral Sclerosis (ALS) Treatments
Date:5/10/2013

SAN DIEGO, May 10, 2013 /PRNewswire-USNewswire/ -- The ALS Emergency Treatment Fund (ALS-ETF) and Denovo Biomarkers (Denovo) have announced a partnership to explore using Denovo's technology to identify potential responder groups for drugs being studied in ALS patients.  This personalized medicine approach may accelerate drug development in ALS and other life-threatening disorders.

The partnership will integrate Denovo's pharmacogenomic technology into the analysis of biological samples obtained from expanded access programs (EAP's) that ALS-ETF sponsors.  By identifying genomic biomarkers that correlate with patients' responsiveness to treatment, the partners seek to identify appropriate patient subsets for the conduct of subsequent trials. 

"This exciting relationship with Denovo Biomarkers may accelerate the development of drugs for ALS and may help us provide useful information for patients and physicians," said Jess Rabourn , Managing Director of ALS-ETF.  Dr. Wen Luo , Chief Scientific Officer for Denovo Biomarkers, noted, "This partnership leverages the mission of ALS-ETF and the broad utility of our platform. We hope that our combined efforts will lead to better, more targeted treatments for ALS."

About The ALS Emergency Treatment Fund (ALS-ETF)

The ALS Emergency Treatment Fund, headquartered in San Francisco, is a nonprofit company created to provide near-term treatment options to sufferers of amyotrophic lateral sclerosis (ALS), a fatal disease that compromises patients' ability to move, speak, swallow and breathe.  ALS-ETF, under license from participating pharmaceutical companies, and as authorized by FDA, implements Expanded Access treatment programs (EAP's) for investigational products in development for ALS. ALS-ETF will also leverage data obtained via EAP's to add scientific value to the clinical development of each compound. By observing a broader spectrum of patients than those typically in registration trials, EAP's may illuminate how subgroups of ALS patients respond to treatment, at different stages of disease progression.  Visit www.alsetf.org.

About Denovo Biomarkers

Denovo Biomarkers, based in San Diego, is a privately-held biotechnology company providing novel biomarker approaches to personalized drug development. The company offers the industry's first platform and algorithm for de novo genomic biomarker discovery using archived clinical samples. This technology is especially useful for compounds with suboptimal aggregate but heterogeneous late-stage trial results.  By identifying biomarkers correlated with patients' response to drug candidates retrospectively, Denovo enables biopharmaceutical manufacturers to design follow-on clinical trials in targeted patient populations while optimizing efficacy, safety and tolerability. Visit www.denovobiomarkers.com.

Contact: 
Jess Rabourn , The ALS Emergency Treatment Fund, jess.rabourn@alsetf.org, (415) 637-4774 
Michael Haller , Denovo Biomarkers, mhaller@denovobiomarkers.com, (858) 876-4012

 


'/>"/>
SOURCE The ALS Emergency Treatment Fund
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medical Guardian Announces Social Media Partnership with Senior Citizen Charity
2. VitaTech Adds New Capacity for Production and Customer Interface, Attributes Growth to Strategic Customer Partnerships
3. Bayer Partnership Delivers Industry-First Dose Management Offering
4. HUYA Bioscience International Engages In Partnership With Zhuhai Sanzao Science and Technology Industrial Park
5. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
6. Medifast Announces International Expansion Into Mexico Through Strategic Partnership with Medix
7. Scotland-based Innova Partnerships Ltd. Opens Boston Office
8. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
9. Partnership Aims to Prevent Students from Misusing Prescription Drugs
10. Tethys Bioscience and Lose it! Announce a Strategic Partnership to Support Diabetes Prevention
11. Drug Delivery Technologies Show Promise of Improving Clinical Outcomes for Patients at PODD: Partnership Opportunities in Drug Delivery Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/13/2018)... ... September 13, 2018 , ... ... a specialist pharmaceutical company focused on developing and commercializing gastrointestinal therapeutics, has ... product. , The U.S. Food and Drug Administration (FDA) and European Medicines ...
(Date:9/12/2018)... ... 12, 2018 , ... Patient experience and population health leader ... Population Engage patient experience suite. Express Surveys are short, streamlined patient experience ... a wealth of strategic and tactical knowledge in order to take meaningful action. ...
(Date:9/12/2018)... ... 12, 2018 , ... Lifetime Wellness , a leading provider of person-centered ... a new online store to offer exclusive aromatherapy products to a wider community. ... open our online store to offer our custom aromatherapy to not only our residents, ...
Breaking Medicine Technology:
(Date:9/1/2018)... , ... August 31, 2018 , ... “Vitamin D is ... of Trivedi Effect, debuted as a hot new release in Vitamins and Supplements, Medical ... She is currently on a media tour around the United States. , With all ...
(Date:8/31/2018)... ... August 31, 2018 , ... Becker's ... , This list includes independent community hospitals as well as facilities affiliated with ... small communities outside of large cities. The hospitals continue to grow in many ...
(Date:8/31/2018)... ... August 31, 2018 , ... The Veterans Affairs (VA) ... to be responsive for procurement purposes. , A 100 million dollar market is ... benefits. Companies like Pacific Medical Training are already offering VA purchasing managers $20 ...
(Date:8/31/2018)... (PRWEB) , ... August 31, 2018 , ... Saturday, September ... as part of the Iowa State Cyclones season opener game. At 7pm, the Cyclones ... as the National Anthem starts to play, Team Fastrax™ will jump in with their ...
(Date:8/29/2018)... ... August 29, 2018 , ... ... announced a new immunization module that allows independent pharmacies to start or ... all-time lows, service-oriented independent pharmacies are moving toward providing immunization programs in ...
Breaking Medicine News(10 mins):